A detailed history of Benedict Financial Advisors Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Benedict Financial Advisors Inc holds 45,931 shares of ABBV stock, worth $8.92 Million. This represents 2.01% of its overall portfolio holdings.

Number of Shares
45,931
Previous 45,523 0.9%
Holding current value
$8.92 Million
Previous $8.29 Million 4.96%
% of portfolio
2.01%
Previous 2.12%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

BUY
$154.79 - $180.76 $63,154 - $73,750
408 Added 0.9%
45,931 $7.88 Million
Q1 2024

Apr 25, 2024

BUY
$159.82 - $182.1 $114,271 - $130,201
715 Added 1.6%
45,523 $8.29 Million
Q4 2023

Jan 29, 2024

BUY
$137.6 - $154.97 $153,974 - $173,411
1,119 Added 2.56%
44,808 $6.94 Million
Q3 2023

Oct 18, 2023

BUY
$133.59 - $154.65 $217,618 - $251,924
1,629 Added 3.87%
43,689 $6.51 Million
Q2 2023

Aug 10, 2023

BUY
$132.51 - $164.9 $136,485 - $169,847
1,030 Added 2.51%
42,060 $5.67 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $359,645 - $414,184
2,487 Added 6.45%
41,030 $6.54 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $172,749 - $207,171
1,249 Added 3.35%
38,543 $6.23 Million
Q3 2022

Nov 07, 2022

BUY
$134.21 - $153.93 $261,709 - $300,163
1,950 Added 5.52%
37,294 $5.01 Million
Q2 2022

Jul 28, 2022

BUY
$137.62 - $174.96 $217,164 - $276,086
1,578 Added 4.67%
35,344 $5.41 Million
Q1 2022

May 03, 2022

BUY
$131.98 - $163.75 $521,057 - $646,485
3,948 Added 13.24%
33,766 $5.47 Million
Q4 2021

Feb 09, 2022

BUY
$107.43 - $135.93 $857,828 - $1.09 Million
7,985 Added 36.57%
29,818 $4.04 Million
Q3 2021

Oct 29, 2021

BUY
$106.4 - $120.78 $481,566 - $546,650
4,526 Added 26.15%
21,833 $2.36 Million
Q2 2021

Aug 05, 2021

BUY
$105.21 - $117.21 $835,156 - $930,412
7,938 Added 84.73%
17,307 $1.95 Million
Q1 2021

May 10, 2021

BUY
$102.3 - $112.62 $195,495 - $215,216
1,911 Added 25.62%
9,369 $1.01 Million
Q4 2020

Feb 02, 2021

BUY
$80.49 - $108.67 $45,879 - $61,941
570 Added 8.28%
7,458 $799,000
Q3 2020

Nov 03, 2020

BUY
$85.91 - $100.83 $344,413 - $404,227
4,009 Added 139.25%
6,888 $603,000
Q2 2020

Jul 23, 2020

BUY
$73.37 - $98.18 $3,961 - $5,301
54 Added 1.91%
2,879 $283,000
Q1 2020

Apr 21, 2020

BUY
$64.5 - $97.79 $4,579 - $6,943
71 Added 2.58%
2,825 $215,000
Q4 2019

Feb 04, 2020

BUY
$72.13 - $90.25 $721 - $902
10 Added 0.36%
2,754 $244,000
Q3 2019

Nov 04, 2019

SELL
$62.98 - $75.72 $19,019 - $22,867
-302 Reduced 9.91%
2,744 $208,000
Q2 2019

Aug 01, 2019

BUY
$65.7 - $83.98 $19,841 - $25,361
302 Added 11.01%
3,046 $221,000
Q1 2019

May 01, 2019

BUY
$77.14 - $90.79 $25,147 - $29,597
326 Added 13.48%
2,744 $221,000
Q4 2018

Jan 30, 2019

BUY
$77.85 - $96.01 $700 - $864
9 Added 0.37%
2,418 $223,000
Q3 2018

Nov 05, 2018

BUY
$88.91 - $98.84 $711 - $790
8 Added 0.33%
2,409 $228,000
Q2 2018

Jul 24, 2018

BUY
$89.78 - $106.23 $628 - $743
7 Added 0.29%
2,401 $222,000
Q1 2018

May 02, 2018

BUY
$92.01 - $123.21 $460 - $616
5 Added 0.21%
2,394 $227,000
Q4 2017

Feb 05, 2018

SELL
$89.56 - $98.21 $26,509 - $29,070
-296 Reduced 11.02%
2,389 $231,000
Q3 2017

Oct 26, 2017

BUY
$69.85 - $89.22 $187,547 - $239,555
2,685
2,685 $239,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $344B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Benedict Financial Advisors Inc Portfolio

Follow Benedict Financial Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benedict Financial Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benedict Financial Advisors Inc with notifications on news.